Clinical Trials List
2024-07-31 - 2031-12-31
Phase III
Recruiting7
ICD-10C50.011
Malignant neoplasm of nipple and areola, right female breast
ICD-10C50.012
Malignant neoplasm of nipple and areola, left female breast
ICD-10C50.019
Malignant neoplasm of nipple and areola, unspecified female breast
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9174.0
Malignant neoplasm of female breast, nipple and areola
-
-
Trial Applicant
-
Sponsor
-
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/05/13
Investigators and Locations
Co-Principal Investigator
- Chen-Teng Wu 無
- Liang-Chih Liu 無
- Yao-Chung Wu 無
- 黃至豪 無
- 蘇孟夏 無
- Chih-Jung Chen 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 黃怡菁 無
- Zhu-Jun Loh 無
- Chun-Hui Lee 無
- 楊舜如 無
- Shang-Hung Chen 無
- Kuo-Ting Lee 無
- Jui-Hung Tsai 無
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 莊博雅 無
- 蔡承志 無
- 廖立民 無
- Yao-Yu Hsieh 無
- HUI-WEN LIU 無
- 蘇智銘 無
- TSU-YI CHAO 無
- KA-WAI TAM 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 陳彥蓁 無
- Ta-Chung Chao 無
- 賴亦貞 無
- Chi-Cheng Huang 無
- 陳柏芳 無
- Chun-Yu Liu 無
- Jiun-I Lai 無
- 邱仁輝 無
- 馮晉榮 無
- 鄭涵方 無
- 林燕淑 無
- Yi-Fang Tsai 無
- 郭懿萱 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Study Contacts
- -
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
Exclusion Criteria
The Estimated Number of Participants
-
Taiwan
6 participants
-
Global
500 participants
